EUVIMED · CrossrefJournal
Gene Therapy
ISSN 0969-7128 · Springer Science and Business Media LLC
Latest articles
Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials
AAV8-PDE6B with 3’UTR provides rescue of photoreceptor structure and function in the rd10 mouse model of retinitis pigmentosa
Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors
In vivo frataxin expression of a triplex purified minicircle
Characterization of CAR-T cell factors that contribute to myeloid cell activation
Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters
SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study
Organoids – the future of pre-clinical development of AAV gene therapy for CNS disorders
In vitro and in vivo rescue of dopaminergic neurons in Parkinson’s disease models after Parkin gene therapy
AAV-mediated gene replacement therapy for LRAT-associated retinitis pigmentosa: a proof-of-concept study in a patient-based rat model
Virus-mediated gene transfer of soluble amyloid precursor protein-alpha via systemic injection in a mouse model of Alzheimer’s disease
Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury
Clinical response to systemic AAV gene therapy in a large animal model of late-stage lysosomal storage disease
Gene augmentation therapy successfully treats mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity
AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice
Environmental and developmental factors shape anti-AAV immunity in pigs
DOCTER: a genetically encoded switchable protein module for ERα-mediated transcriptional regulation
Research progress and development strategies of antibody-oligonucleotide conjugates
rAAV8 encapsidated HMR-001/z enables high efficiency hepatic transduction and restores hemostasis in hemophilic mice
A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy
Precision rewriting of muscle genetics: therapeutic horizons of base and prime editing in skeletal muscle disorders
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA’s conclusions from the evaluation of 38 suspected cases
Metadata assessment of non-human primate studies of AAV9 uncovers potential tissue specific variation in expression efficiency
Building a gene editing lexicon: a model for rare and inherited disorders
Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liver
The poly-(HA-GMA) hydrogel carrying AAV8-sTβRII alleviates scar formation in mice skin wound healing by inhibiting fibrosis
CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs
EUVIMED